178 related articles for article (PubMed ID: 11104672)
1. In vitro-selected RNA cleaving DNA enzymes from a combinatorial library are potent inhibitors of HIV-1 gene expression.
Sriram B; Banerjea AC
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):667-73. PubMed ID: 11104672
[TBL] [Abstract][Full Text] [Related]
2. In vitro selected RNA-cleaving DNA enzymes from combinatorial libraries.
Chakraborti S; Sriram B; Banerjea AC
Methods Mol Biol; 2004; 252():279-90. PubMed ID: 15017057
[TBL] [Abstract][Full Text] [Related]
3. Identification of cleavage sites in the HIV-1 TAR RNA by 10-23 and 8-17 catalytic motif containing DNA enzymes.
Chakraborti S; Banerjea AC
Biomacromolecules; 2003; 4(3):568-71. PubMed ID: 12741771
[TBL] [Abstract][Full Text] [Related]
4. A new and efficient DNA enzyme for the sequence-specific cleavage of RNA.
Feldman AR; Sen D
J Mol Biol; 2001 Oct; 313(2):283-94. PubMed ID: 11800557
[TBL] [Abstract][Full Text] [Related]
5. Potent knock down of HIV-1 replication by targeting HIV-1 Tat/Rev RNA sequences synergistically with catalytic RNA and DNA.
Sood V; Unwalla H; Gupta N; Chakraborti S; Banerjea AC
AIDS; 2007 Jan; 21(1):31-40. PubMed ID: 17148965
[TBL] [Abstract][Full Text] [Related]
6. Gaining target access for deoxyribozymes.
Schubert S; Fürste JP; Werk D; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
J Mol Biol; 2004 May; 339(2):355-63. PubMed ID: 15136038
[TBL] [Abstract][Full Text] [Related]
7. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme.
Unwalla H; Chakraborti S; Sood V; Gupta N; Banerjea AC
Antiviral Res; 2006 Nov; 72(2):134-44. PubMed ID: 16790281
[TBL] [Abstract][Full Text] [Related]
8. A novel mode of regulation of an RNA-cleaving DNAzyme by effectors that bind to both enzyme and substrate.
Wang DY; Sen D
J Mol Biol; 2001 Jul; 310(4):723-34. PubMed ID: 11453683
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA.
Unwalla H; Banerjea AC
Biochem J; 2001 Jul; 357(Pt 1):147-55. PubMed ID: 11415445
[TBL] [Abstract][Full Text] [Related]
10. DNA-enzyme-mediated cleavage of human immunodeficiency virus type 1 Gag RNA is significantly augmented by antisense-DNA molecules targeted to hybridize close to the cleavage site.
Sood V; Gupta N; Bano AS; Banerjea AC
Oligonucleotides; 2007; 17(1):113-21. PubMed ID: 17461768
[TBL] [Abstract][Full Text] [Related]
11. A general strategy for effector-mediated control of RNA-cleaving ribozymes and DNA enzymes.
Wang DY; Lai BH; Sen D
J Mol Biol; 2002 Apr; 318(1):33-43. PubMed ID: 12054766
[TBL] [Abstract][Full Text] [Related]
12. In vitro evolution of an RNA-cleaving DNA enzyme into an RNA ligase switches the selectivity from 3'-5' to 2'-5'.
Flynn-Charlebois A; Prior TK; Hoadley KA; Silverman SK
J Am Chem Soc; 2003 May; 125(18):5346-50. PubMed ID: 12720447
[TBL] [Abstract][Full Text] [Related]
13. A genomic selection strategy to identify accessible and dimerization blocking targets in the 5'-UTR of HIV-1 RNA.
Jakobsen MR; Damgaard CK; Andersen ES; Podhajska A; Kjems J
Nucleic Acids Res; 2004 Apr; 32(7):e67. PubMed ID: 15107482
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HIV-1 gene expression by novel DNA enzymes targeted to cleave HIV-1 TAR RNA: potential effectiveness against all HIV-1 isolates.
Chakraborti S; Banerjea AC
Mol Ther; 2003 Jun; 7(6):817-26. PubMed ID: 12788656
[TBL] [Abstract][Full Text] [Related]
15. In vitro cleavage of hepatitis B virus C mRNA by 10-23 DNA enzyme.
Hou W; Wo JE; Li MW; Liu KZ
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):573-6. PubMed ID: 16286265
[TBL] [Abstract][Full Text] [Related]
16. Silencing of HIV-1 with RNA interference: a multiple shRNA approach.
ter Brake O; Konstantinova P; Ceylan M; Berkhout B
Mol Ther; 2006 Dec; 14(6):883-92. PubMed ID: 16959541
[TBL] [Abstract][Full Text] [Related]
17. Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs.
von Eije KJ; ter Brake O; Berkhout B
J Gene Med; 2009 Jun; 11(6):459-67. PubMed ID: 19384894
[TBL] [Abstract][Full Text] [Related]
18. Tracing sequence diversity change of RNA-cleaving deoxyribozymes under increasing selection pressure during in vitro selection.
Schlosser K; Li Y
Biochemistry; 2004 Aug; 43(30):9695-707. PubMed ID: 15274624
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.
Han W; Wind-Rotolo M; Kirkman RL; Morrow CD
Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848
[TBL] [Abstract][Full Text] [Related]
20. Prospects for antiviral ribozymes and deoxyribozymes.
Peracchi A
Rev Med Virol; 2004; 14(1):47-64. PubMed ID: 14716691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
